What's Happening?
Reed Garrett, a pitcher for the New York Mets, will miss the entire 2026 season following Tommy John surgery. Garrett's surgery comes after months of dealing with elbow issues, which initially began with inflammation and later revealed a sprain. The procedure is expected to sideline him for 12-18 months. Garrett's absence will impact the Mets' bullpen, which is already facing potential changes with several players eligible for free agency.
Why It's Important?
Tommy John surgery is a significant procedure for pitchers, often requiring lengthy recovery periods. Garrett's absence will necessitate strategic adjustments for the Mets as they plan their bullpen for the next season. The team will need to consider replacements and potential acquisitions to fill the gap left by Garrett. This development also highlights the physical demands and risks associated with professional baseball, impacting team dynamics and player careers.
What's Next?
The Mets will need to make decisions regarding their bullpen composition, considering Garrett's absence and the potential free agency of other key players. The team may explore trades or sign new talent to maintain competitiveness. Garrett's recovery will be closely monitored, with hopes for a successful return post-surgery.
